The Effect of Therapeutic Hypothermia on Reducing Neurological Complications in Newborns with Birth Asphyxia
Journal of Clinical Peadiatrics and Care · 2026
DOI: 10.58489/2836-8630/021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Peadiatrics and Care, 2026. Verfasst von Mohamed Zaeim Hafez.
Abstract (Originalsprache)
Objective: this study was to evaluate the effect of therapeutic hypothermia on reducing neurological complications in newborns with birth asphyxia.
Methods
A prospective randomized comparative study was conducted on newborns diagnosed with birth asphyxia who were admitted to the Neonatal Intensive Care Unit (NICU) of Al-Azhar University Hospital, Assiut, during the study period. Eligible newborns were divided into two groups: group I was a therapeutic hypothermia group (n = 185) and group II was a standard care group (n=182). The time from birth to randomization was recorded for all included newborns.
Results
Therapeutic hypothermia significantly reduced the burden of early neurological complications during the NICU stay. Clinical seizures occurred in 29.2% of the TH group versus 48.9% of the SC group (RR = 0.60; 95% CI: 0.46–0.78; p < 0.001), representing a 19.7-percentage-point reduction, while electrographic seizures were detected in 25.9% versus 45.1% (RR = 0.58; 95% CI: 0.44–0.76; p
Zitieren
APA
Hafez, M. Z. (2026). The Effect of Therapeutic Hypothermia on Reducing Neurological Complications in Newborns with Birth Asphyxia. Journal of Clinical Peadiatrics and Care. https://doi.org/10.58489/2836-8630/021
Vancouver
Hafez MZ. The Effect of Therapeutic Hypothermia on Reducing Neurological Complications in Newborns with Birth Asphyxia. Journal of Clinical Peadiatrics and Care. 2026. doi:10.58489/2836-8630/021
BibTeX
@article{Hafez2026,
author = {Hafez, Mohamed Zaeim},
title = {The Effect of Therapeutic Hypothermia on Reducing Neurological Complications in Newborns with Birth Asphyxia},
journal = {Journal of Clinical Peadiatrics and Care},
year = {2026},
doi = {10.58489/2836-8630/021}
}
EUVIMED